DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Abramson JS, Palomba ML, Gordon LI. et al.
Pivotal safety and efficacy results from transcend NHL 001, a multicenter Phase 1 study of lisocabtagene maraleucel (liso-cel) in relapsed/refractory (R/R) large B cell lymphomas.
Blood 2019;
134 (Suppl. 01) 241
Access:
We do not assume any responsibility for the contents of the web pages of other providers.